Riskpilot← Back to searchSign inGet full accessImpregnum AB
ABActiveOrg 5565202909Stenbrovägen 40Wholesale of chemical products · NACE 4685Est. 19952 employees
Revenue 2025
SEK 893K
-33% vs 2024
EBITDA margin
-46.9%
-424% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
SEK -426K
-1362% vs 2024
| Revenue | SEK 893K | -33% |
| EBITDA | SEK -419K | -424% |
| Net profit | SEK -426K | -1362% |
| Total assets | SEK 6,3M | -25% |
| Equity | SEK 6,3M | -9% |
| Employees | 2 | — |
Legal name
Impregnum AB
Org number
5565202909
Legal form
Aktiebolag
NACE code
4685 · Wholesale of chemical products
Founded
17 juli 1995
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva marknadsföring, försäljning av kemisktekniska produkter, samt konsultationer inom nämnda verksamhetsområde, handelsverksamhet med konsumentprodukter inom djur- och fritid och därmed förenlig verksamhet.
Address
Stenbrovägen 40
Phone
+4642263700
Email
info@impregnum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 065 | 2 339 | 1 580 | 1 332 | 893 |
| Staff expenses | — | −558 | −547 | −415 | −329 |
| EBITDA | 243 | 276 | 7 817 | −80 | −419 |
| Depreciation & amort. | −0 | — | — | — | −25 |
| EBIT | 243 | 276 | 7 817 | −80 | −444 |
| Net financials | 20 | 255 | 1 | 51 | 18 |
| Profit before tax | 356 | 640 | 8 390 | −29 | −426 |
| Tax | −67 | −76 | −1 737 | — | — |
| Net profit | 289 | 565 | 6 653 | −29 | −426 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 602 | 2 839 | 9 978 | 8 370 | 6 319 |
| Equity | 1 157 | 1 422 | 7 774 | 6 909 | 6 284 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 762 | 845 | 2 203 | 1 461 | 36 |
| Total debt | 762 | 845 | 2 203 | 1 461 | 36 |
EBITDA margin
-46.9%
This company
15.8%
Market median
-397% vs market
20212025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
-6.8%
This company
18.4%
Market median
-137% vs market
20212025
Net profit margin
-47.7%
This company
8.1%
Market median
-689% vs market
20212025
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Impregnum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wioletta Pilhav-Jansson | Deputy Board Member | 0 companies |
| Sten Gunnar Helge Jansson | Board of Directors | 0 companies |